Target intelligence / Profile preview

TMEM212 antisense RNA 1 (TMEM212-AS1)

Target
TMEM212-AS1
Molecular classification
Long non-coding RNA, Antisense RNA
01

Overview

TMEM212 antisense RNA 1 (TMEM212-AS1) is a long non-coding antisense RNA gene located in the human genome and transcribed opposite to the protein-coding TMEM212 locus. Like other antisense lncRNAs, TMEM212-AS1 may regulate the expression of its sense gene via mechanisms including RNA duplex formation, modulation of transcription, or interactions with RNA-binding proteins, though no specific functions or disease associations have been reported for TMEM212-AS1 as of the current data. Antisense lncRNAs more broadly are known to have potential roles in developmental regulation, imprinting, and disease, but there is no experimentally validated functional or disease evidence for TMEM212-AS1 in the literature at present. TMEM212-AS1 is a human long non-coding antisense RNA gene; it is neither a receptor nor a typical drug target. There are currently no disease associations, biomarkers, or drug interactions reported for this molecule. It is correctly named and classified as a lncRNA/antisense RNA, but further experimental data are needed to detail its biological or pharmacological significance.

Other names
TMEM212 antisense RNA 1TMEM212-AS1
02

Mechanism of action

Not applicable; no drugs known to target TMEM212-AS1

03

Biological functions

Regulation of gene expression (through antisense pairing to TMEM212 mRNA)May influence transcription, translation, or RNA stability based on general lncRNA/antisense RNA mechanisms
04

Disease associations

Other (no direct disease association or published evidence specific to TMEM212-AS1 as of the current search results. Other antisense lncRNAs are linked to cancer and gene imprinting, but there is no published disease link for TMEM212-AS1 itself)

Beyond the preview

Go deeper on TMEM212 antisense RNA 1 (TMEM212-AS1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on TMEM212 antisense RNA 1 (TMEM212-AS1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call